New business is being written on visibly better terms than the company's own recent norm, and the mix shift has just beg
The model's full reasoning — Q2 2023 call → NOWe need answer only YES or NO. Need evaluate based on transcript. Question asks about economic terms of company's newest business stepping up meaningfully above own recent norm and improvement only begun to flow into reported results. Need see if management indicates both halves. Transcript is Nanobiotix earnings call. They discuss partnership with Janssen: global license agreement, upfront $30M, equity, milestones $1.8B, royalties. This is a new deal. Is that "newest business" terms improved vs own recent norm? They also mention LianBio collaboration. But question likely about business terms of deals/contracts. Management describes Janssen deal as transformative, attractive, near-term and long-term value, up to $60M near-term, $30M equity, success-based payments over $1.8B, tiered double-digit royalties. Is this a step-up vs own recent norm? They don't explicitly compare to prior deals. They say "we believe this partnership underscores therapeutic and market opportunities" and "offers both near-term and long-term value". But no explicit comparison to company's own recent terms. Also reported results still mostly reflect old terms? They mention cash runway extends into Q1 2024, not taking into account future financing. But not about revenue mix. The question is about "economic terms of company's newest business" - maybe the Janssen deal is a new collaboration with better economics than previous LianBio? But management doesn't say "compared to our own recent norm" or "improvement only begun to flow into reported results". They do say "we are pleased this deal has helped strengthen our balance sheet and extend our cash on the way into first quarter of 2024, including through some key clinical catalysts." But that's about cash, not revenue. Need answer NO because management does not convey both halves. They don't describe that reported results still mostly reflect old terms. They don't compare terms to own recent past. So NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| BRKL | Brookline Bancorp, Inc. | Q2 2022 | 2022-07-30 | B+ |
| INVH | Invitation Homes Inc. | Q2 2022 | 2022-07-28 | B+ |
| MTB | M&T Bank Corporation | Q2 2022 | 2022-07-20 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
CRL · Q2 2022 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management's comments on Safety Assessment pricing and backlog directly address both required elements: they describe current bookings and backlog at "escalating prices" and "meaningful price increases" that are already achieved on real transactions (not targets or future expectations), while noting that the reported Q2 results are still dominated by older 2022 terms and that the stronger pricing is accelerating into H2 and 2023 bookings.
ESS · Q2 2018 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management describes the loss-to-lease metric rising to 3.
CTO · Q2 2023 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...